| Kathryn Wing, | |
|
400 Mill Plain Rd, Fairfield, CT 06824-5048 | |
| (203) 292-4702 | |
| Not Available |
| Full Name | Kathryn Wing |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 400 Mill Plain Rd, Fairfield, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164070447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Wing, 46 Concord Dr, Rocky Hill, CT 06067-2144 Ph: () - | Kathryn Wing, 400 Mill Plain Rd, Fairfield, CT 06824-5048 Ph: (203) 292-4702 |
News Archive
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.
Genta Incorporated today announced that the Company has initiated a new Phase 2b clinical trial of tesetaxel as 1st-line chemotherapy for women with metastatic breast cancer. Tesetaxel is the leading oral taxane currently in clinical development. The new trial will be conducted at Memorial Sloan-Kettering Cancer Center, New York, NY and at the Accelerated Community Oncology Research Network (ACORN) based in Memphis, TN.
Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.
YM BioSciences Inc., today reported that the Phase I/II clinical trial for its orally available JAK1/JAK2 inhibitor, CYT387, in patients with myelofibrosis has been expanded to five sites. Of the additional sites, the Stanford Cancer Center (Stanford, California) under Principal Investigator Jason Gotlib, MD has already commenced enrolling patients.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced receipt from Mallinckrodt Inc., a Covidien company (Covidien), of top-line results from a Phase 2 study conducted by Covidien, of twice-daily administration of PENNSAID Viscous Solution (topical diclofenac sodium viscous solution) 2% w/w, previously referred to as PENNSAID Gel.
› Verified 9 days ago
Lainie Mchugh, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1931 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-384-8681 | |
Mrs. Rebecca Lynne Petrosino, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2373 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-659-4898 Fax: 203-659-4899 | |
Restore Health Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2060 Post Rd, Fairfield, CT 06824 Phone: 203-435-0350 | |
Miss Hanna Mary Gleason, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1499 Post Rd Lowr Level, Fairfield, CT 06824 Phone: 203-445-0845 | |
Gail Weintraub, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Mill Plain Rd, Fairfield, CT 06824 Phone: 203-255-3573 | |
Laura M Delladonna, RPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 305 Black Rock Tpke, Fairfield, CT 06825 Phone: 203-337-2600 Fax: 203-337-2611 | |
Center For Pediatric Therapy-fairfield, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1300 Post Rd, Suite 204, Fairfield, CT 06824 Phone: 203-255-3669 Fax: 205-255-1173 |